Press releases

Orchard Therapeutics Appoints Joanne Beck, Ph.D. to Board of Directors

Orchard Therapeutics today announced the appointment of Joanne Beck, Ph.D., to its board of directors. Dr. Beck is currently the executive vice president of pharmaceutical development and operations and a member of the executive committee at Celgene

Read more

Orchard Therapeutics Appoints Jim Geraghty as Chairman of its Board of Directors

Orchard Therapeutics today announced the appointment of Jim Geraghty as chairman of its board of directors. Ben Auspitz, a partner at F-Prime Capital, who served as Orchard’s chairman since 2016, will transition from his current role on the board

Read more

Orchard Therapeutics Announces Appointments of Marc Dunoyer and Charlie Rowland to Board of Directors

Orchard Therapeutics today announced the appointments of Marc Dunoyer and Charlie Rowland to its board of directors as independent directors

Read more

Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of Metachromatic Leukodystrophy

Orchard’s fourth Rare Pediatric Disease Designation for autologous ex vivo gene therapy

Read more

Orchard Therapeutics Expands US Presence with New Corporate Office in Boston

Orchard Therapeutics today announced the opening of a new U.S. office in Boston’s Seaport District. The new Boston office builds upon the company’s footprint in London as well as Foster City and Menlo Park, California

Read more